Cathie Wood's ARK Innovation Stocks Performance Guide: Pacific Biosciences of Calif (PACB)
PACB has no dividends.
Table and Chart of PACB Performance
See what a $1,000 investment in PACB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PACB Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $6.56 |
| End Date | Oct-10-2024 |
| End Price | $1.55 |
| # Prices | 121 |
| Min Date | Aug-30-2024 |
| Min Price | $1.37 |
| Max Date | Jun-30-2021 |
| Max Price | $34.97 |
| Total Return | -76.37% |
| Annualized Return | -13.33% |
| Current Value of $1,000 Purchase | $236 |
| Number Returns | 7,260 |
| Average Return | 75.99% |
| Number Profitable Returns | 3,775 |
| Percent Profitable Returns | 52.00% |
| Number Unprofitable Returns | 3,485 |
| Percent Unprofitable Returns | 48.00% |
| Profitable to Unprofitable Returns Ratio | 1.08 |
| PACB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -4.154 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -267694000 |
| PE to Growth Ratio | None |
| Price to Book | 2.323 |
| PRICE DATA | |
| 52 Week High | $2.045 |
| 52 Week Low | $10.65 |
| Analyst Target Price | $-0.243 |
| 50-Day Moving Average | $1.16 |
| 200-Day Moving Average | $1.632 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.5 |
| Revenue | $-1 |
| Profit Margin | 71% |
| Return on Equity | -11.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PACB Compare Returns with S&P 500
PACB Trendline Chart
PACB Moving Average Chart
PACB Stock Return Map - See Patterns of Gains and Losses
PACB Stock Returns/Purchase Dates